Latest Singapore News

Steadfast Group confirms the consortium led by Amwins, Dragoneer, and KKR is progressing its $6 per share cash acquisition proposal, with due diligence substantially complete and exclusivity extended to 19 August 2026.

ClearVue Technologies bolstered its balance sheet with a A$6 million capital raise while landing high-profile projects including Canva’s Sydney HQ and its first European contract in Cyprus. The company also advanced international expansion and achieved key certifications confirming product durability and safety.

Novatti Group Limited delivered a 5% quarter-on-quarter revenue increase to $7.6 million in Q4 FY26, driven by its Payments AU/NZ segment's strong 8% revenue and 26% margin growth. The company achieved positive EBITDA of $0.3 million, boosted by a 95% jump in Payments AU/NZ EBITDA to $0.9 million.

GreenX Metals has outlined a substantial Exploration Target at its Tannenberg Copper Project in Germany, confirming its geological similarity to major Polish Kupferschiefer mines and setting the stage for active drilling and metallurgical work. Concurrently, fieldwork at the Eleonore North Project in Greenland has identified new high-priority tungsten and antimony targets, while a key legal challenge in Singapore was dismissed, affirming GreenX’s compensation rights.

Island Pharmaceuticals has marked a major step forward in its antiviral program with the start of GMP manufacturing for Galidesivir, expanded USAMRIID collaboration, and FDA orphan drug designation. Regulatory approvals for compassionate use in Uganda’s Ebola outbreak and a new dose optimisation study with Texas Biomed further de-risk the pathway to approval.

dorsaVi has confirmed its RRAM memory and neuromorphic IP operate synergistically, projecting up to 10x performance gains for robotics and exoskeletons. The company also finalized its first integrated RRAM-CMOS validation chip design, advancing towards tape-out and commercialisation.

De.mem Limited posted its second highest quarterly cash receipts of approximately $9.6 million for June 2026, marking 29 consecutive quarters of growth and positive operating cash flow of $424k. The company’s strong half-year performance is underpinned by recurring revenues, a robust Western Australian business, and record results from its German subsidiary.

Perpetual Limited recorded solid growth across its divisions in Q4 FY26, with Corporate Trust and Asset Management buoyed by market gains despite net outflows. The company is advancing the sale of its Wealth Management arm to Bain Capital, targeting completion in late 2026.

DXN Limited has landed a $1.2 million contract for a key Pacific submarine cable project while advancing its maiden AI HPC modular data centre deal and expanding manufacturing in Southeast Asia.

Battery Age Minerals has identified multiple priority exploration targets at its Apex Project in Utah, submitted new drilling permits for Austria’s Bleiberg site, finalised a commercial germanium technology licence, and gained entry to a US defense consortium, underpinning its integrated germanium strategy.

Critical Resources (ASX:CRR) spotlighted its multi-commodity pipeline and breakthrough battery cooling technology at the July 2026 TechKnow Invest Roadshow, highlighting exploration progress and exclusive global licensing deals.

Firebrick Pharma expanded its patent portfolio with grants in Canada and New Zealand while achieving 43% sales growth in FY26 despite steady operating expenses. The company is advancing Nasodine's commercial rollout across Southeast Asia and the US.